- Home
- EVO vs TUYA Comparison
EVO vs TUYA Comparison
Compare EVO & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- TUYA
- Stock Information
- Founded
- EVO 1993
- TUYA 2014
- Country
- EVO Germany
- TUYA China
- Employees
- EVO N/A
- TUYA N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- TUYA Computer Software: Prepackaged Software
- Sector
- EVO Health Care
- TUYA Technology
- Exchange
- EVO Nasdaq
- TUYA Nasdaq
- Market Cap
- EVO 1.5B
- TUYA 1.2B
- IPO Year
- EVO 2021
- TUYA 2021
- Fundamental
- Price
- EVO $4.30
- TUYA $2.32
- Analyst Decision
- EVO Buy
- TUYA
- Analyst Count
- EVO 2
- TUYA 0
- Target Price
- EVO $5.90
- TUYA N/A
- AVG Volume (30 Days)
- EVO 154.6K
- TUYA 1.7M
- Earning Date
- EVO 05-06-2025
- TUYA 05-19-2025
- Dividend Yield
- EVO N/A
- TUYA 4.69%
- EPS Growth
- EVO N/A
- TUYA N/A
- EPS
- EVO N/A
- TUYA 0.01
- Revenue
- EVO $851,944,444.00
- TUYA $298,617,000.00
- Revenue This Year
- EVO $11.29
- TUYA $22.34
- Revenue Next Year
- EVO $13.20
- TUYA $18.11
- P/E Ratio
- EVO N/A
- TUYA $266.42
- Revenue Growth
- EVO 1.50
- TUYA 29.84
- 52 Week Low
- EVO $2.84
- TUYA $1.28
- 52 Week High
- EVO $5.68
- TUYA $4.63
- Technical
- Relative Strength Index (RSI)
- EVO 61.35
- TUYA 46.06
- Support Level
- EVO $3.91
- TUYA $2.21
- Resistance Level
- EVO $4.38
- TUYA $2.46
- Average True Range (ATR)
- EVO 0.13
- TUYA 0.14
- MACD
- EVO 0.01
- TUYA 0.06
- Stochastic Oscillator
- EVO 86.89
- TUYA 69.32
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.